BackAllergan plc Overview

Allergan plc Total Liabilities

Latest total liabilities for AGN: $30B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$30.43B
↓ 16.62% YoYΔ $-6.07B vs prior year quarter

Peer trimmed avg / median

Loading

Allergan plc Total Liabilities History

Loading

Allergan plc vs. peers: Total Liabilities Comparison

Loading

Allergan plc Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Allergan plc (AGN) FAQ

As of the most recent data (March 2020), AGN shows a total liabilities of $30B. That compares with $36B in the prior-year period — down 16.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AGN's total liabilities is now $30B (was $36B) — a 16.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Allergan plc is outperforming or lagging.

Tracking AGN's total liabilities over time shows whether Allergan plc is scaling, shrinking, or reshaping that part of the business. The current reading is $30B That compares with $36B in the prior-year period — down 16.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Allergan plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $30B) with ownership activity and broader fundamentals.

Allergan plc's total liabilities is $30B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.